Insight Molecular Diagnostics (IMDX) Gross Margin (2020 - 2026)
Insight Molecular Diagnostics (IMDX) reported Gross Margin of 65.69% for Q2 2026, up 0.44 percentage points from 65.25% a year earlier and up 18.82 percentage points from the prior quarter.
Powered by 
Analysis
Insight Molecular Diagnostics (IMDX) Gross Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Insight Molecular Diagnostics' Gross Margin came in at 48.32%, down 5.89 percentage points year-over-year; for FY2025, it came in at 56.67%, up 17.33 percentage points from FY2024.
- Gross Margin has increased for three consecutive years, with a five-year change of +109.22 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 39.34% in FY2024 (+11.86 pp), 27.48% in FY2023 (+29.36 pp), -1.88% in FY2022 (-66.48 pp) and 64.60% in FY2021 (+117.15 pp).
- The Q2 2026 figure ranks as the highest quarterly Gross Margin since Q4 2021.
- Year over year, Gross Margin gained in six of the last eight quarters, with an average year-over-year change of +14.42 percentage points.
- The high point for year-over-year Gross Margin in five years was Q3 2023 (a gain of 459.30 percentage points); the low point was Q3 2022 (a drop of 313.48 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 46.88% (Q1 2026), 43.55% (Q4 2025) and 53.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 40.70% |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 57.71% |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 57.64% |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 67.78% |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 64.99% |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 68.27% |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 70.71% |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 46.46% |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 77.46% |
| 10 | Insight Molecular Diagnostics | 103.74 Mn | 27.46 Mn | 157,000.00 | 65.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.69% |
| Mar 31, 2026 | 46.88% |
| Dec 31, 2025 | 43.55% |
| Sep 30, 2025 | 53.46% |
| Jun 30, 2025 | 65.25% |
| Mar 31, 2025 | 61.97% |
| Dec 31, 2024 | 40.04% |
| Sep 30, 2024 | 43.48% |
| Jun 30, 2024 | 48.08% |
| Mar 31, 2024 | 25.57% |
| Dec 31, 2023 | -37.26% |
| Sep 30, 2023 | 57.81% |
| Jun 30, 2023 | 58.75% |
| Mar 31, 2023 | 3.37% |
| Dec 31, 2022 | -9.85% |
| Sep 30, 2022 | -401.49% |
| Jun 30, 2022 | 13.08% |
| Mar 31, 2022 | 65.00% |
| Dec 31, 2021 | 72.47% |
| Sep 30, 2021 | -88.01% |
API Access
Insight Molecular Diagnostics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();